Close Menu

Proteome Sciences

Proteome Sciences announced this week positive results from research testing several compounds as inhibitors against the candidate Alzheimer's drug target casein kinase 1 delta, or CK1δ.

Ohio State University of Columbus, Ohio, has received US Patent No. 8,075,854, "Microfluidic chips for rapid multiplex ELISA. "The patent claims a microfluidic chip that consists of a substrate and a channel or multiple channels in the substrate.

Proteome Sciences said this week it has signed an agreement with Siena Biotech making it the preferred supplier of protein and peptide biomarker services for Siena's drug development research.

The firm, Proteomedix Frontiers, has developed SRM-MS assays for more than 400 proteins that could be important to drug development efforts. It plans to offer them to pharma researchers both as kits and through agreements with contract research organizations.

People in the News

Premium

David Okrongly, Martin Madaus, Glenn Barney

Pages

According to New Scientist, GEDmatch changed its terms and conditions over the weekend to opt its users out of law enforcement searches.

The Atlantic looks into time spent pursuing gene leads generated through candidate gene studies.

A twin study uncovers evidence that genes may influence whether someone gets a dog, Martha Stewart reports.

In PNAS this week: Cdx2 cells can help regenerate heart tissue in mice following a heart attack, PIWI-interacting small RNA levels in human cancer, and more.